In a Diabetes Care randomized trial, The study’s glucose management approach using CGM did not improve glucose levels compared with standard glucose management in the non-intensive care unit hospital setting. Key reported results included For the 110 participants included in the primary analysis…
Author: Hormone Insight Editorial Team
Read More
In a J Clin Endocrinol Metab randomized trial, Treatment with ROMO significantly increased lumbar spine BMD in glucocorticoid-treated patients, suggesting that ROMO is effective for GIOP. Key reported results included Eleven patients were assigned to the ROMO group, 14 to the DMAb group, and 14 to…
In a N Engl J Med randomized trial, Three years of treatment with tirzepatide in persons with obesity and prediabetes resulted in substantial and sustained weight reduction and a markedly lower risk of progression to type 2 diabetes than that with placebo. Key reported results included At 176…
In a J Clin Endocrinol Metab randomized trial, All patterns of light-intensity walking reduced postprandial glucose concentrations and diastolic BP in young obese adults, suggesting benefits for glycemic control. Key reported results included Compared with SIT, all walking conditions reduced iAUCs…
In a J Clin Endocrinol Metab randomized trial, PM tended to increase P1NP in older women with T2D, as well as increasing bone density and reducing HbA1c. Key reported results included P1NP increased 23.0% with PM (95% CI 9, 37; within group P = .028) vs 4.1% with placebo (-9, 17; within group P =…
In a J Clin Endocrinol Metab randomized trial, Ultrasound alone appears to be an effective diagnostic modality in thyroid nodules, confirming the recommendations of recent guidelines and the British Thyroid Association classification. Key reported results included Of the 982 participants, a final…
In a Diabetes Care randomized trial, In older adults with T1D and high risk of hypoglycemia, CGM use enhanced by geriatric principles can lower hypoglycemia without worsening glycemic control in a cost-effective fashion. Key reported results included We randomized 131 participants (aged 71 ± 5…
In a J Clin Endocrinol Metab randomized trial, The reported efficacy, pharmacokinetic, pharmacodynamic, safety, and immunogenicity data support the biosimilarity of SB16 to DEN. Key reported results included The least-squares mean differences in percent change from baseline in lumbar spine BMD at…
In a Diabetes Care randomized trial, Glucagon antagonism enhances the therapeutic effects of SGLT2 inhibition in type 1 diabetes. Key reported results included Average glucose and percent time with glucose in range (70-180 mg/dL) improved with combination therapy versus Baseline and SGLT2…
In a J Clin Endocrinol Metab randomized trial, We found no evidence that SGTF was associated with differences in adolescent brain morphology, and no effect of levothyroxine supplementation. Key reported results included There were no significant differences in global brain volumetric measures…